AMERICAN SOCIETY FOR RADIATION ONCOLOGY for AMERICAN SOCIETY FOR RADIATION ONCOLOGY
What was lobbied
4 issue areas, each in the filer's own words, with who lobbied on it and where.
Budget/Appropriations BUD
H Con Res 85, FY 2010 Budget Resolution to increase cancer research funding, to rebase the Medicare physician fee schedule and to close the Medicare in-office ancillary services loophole for radiation therapy services, and increase cancer research funding.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DAVID ADLER | — |
| RICHARD J MARTIN | — |
| EMILY WILSON | — |
Homeland Security HOM
To protect access to medical isotopes used in cancer treatments such as brachytherapy and stereotactic radiosurgery. Development of domestic medical isotope production.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DAVID ADLER | — |
| RICHARD J MARTIN | — |
| EMILY WILSON | — |
Health Issues HCR
Support for legislation to reform health care through a combination of public and private approaches to cover medically necessary services, support review and development of national workforce strategy including elimination of pre-existing condition limitations. Support for health care reform provisions in the Affordable Health Choices Act such as consumer protection from annual and lifetime insurance limits and expanded access to and use of regular health assessments and preventive services, including early screening and detection. Support of funding for the Caroline Pryce Walker Conquer Childhood Cancer Act (P.L. 110-285) in the FY 2010 Labor, Health and Human Services, Education, and Related Agencies Appropriations Act. Support funding for the development of domestic medical isotope production. Support for the Access to Cancer Clinical Trials Act of 2009 (S. 488, H.R. 716) to provide access to clinical trials for cancer patients. Support of health care reform legislation. Support for the 21st Century Cancer ALERT bill (S 717) to modernize cancer research, increase access to preventative cancer services, provide cancer treatment and survivorship initiatives, and for other purposes.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DAVID ADLER | — |
| RICHARD J MARTIN | — |
| EMILY WILSON | — |
Medicare/Medicaid MMM
Support for legislation to reform the Medicare physician payment formulat to stabilize physician payments. Support for legislation to insure patient safety and preserve the integrity of the Medicare program by ending abuses of the physician self-referral law for radiation therapy services. Support for H.R. 3095 to provide Medicare coverage for cancer patients. Comprehensive Cancer Care Improvement Act of 2009 (HR 1844) to expand cancer care planning, comprehensive symptom management and to authorize demonstrations for hospice and palliative care for cancer patients. Legislation to support structural changes that lead to deliverying high-quality care for patients while increasing efficiencies and promoting Medicare sustainability; oppose radiation oncology benefit managers. Support for S1213 to provide funding for comparative effectiveness research.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DAVID ADLER | — |
| RICHARD J MARTIN | — |
| EMILY WILSON | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.